2008

Fernandez P, Viebig NK, Dechavanne S, Lépolard C, Gysin J, Scherf A, Gamain B. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. Malaria Journal. 2008; 7:170 (Var2-CSA DBL3-X)

Faber BW, Remarque EJ, Kocken CH, Cheront P, Cingolani D, Xhonneux F, Jurado M, Haumont M, Jepsen S, Leroy O, Thomas AW. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. Vaccine. 2008 Nov 11;26(48):6143.50 (AMA1 FVO)

Nebie, A. Diarra, A. Ouedraogo, I. Soulama, E. Bougouma, A. Tiono, A. Konate, R. Chilengi, M. Theisen, D. Dodoo, E. Remarque, S. Bosomprah, P. Milligan and S. Sirima, "Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso," West Africa Infect Immun, vol. 76, no. 2, pp. 759-66, 2008 (AMA1-DiCo)

Roestenberg M, Remarque E, de Jonge E, Hermsen R, Blythman H, Leroy O,Imoukhuede E, Jepsen S, Ofori-Anyinam O, Faber B, Kocken CHM, Arnold M, Walraven V, Teelen K, Roeffen W, de Mast Q, Ballou WR, Cohen J, Dubois MC, Ascarateil S, van der Ven A, Thomas A, Sauerwein R. Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or ASO2. PLoS one. 2008 Dec; 3(12):e3960 (AMA1)